ArticleCancers2025

Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center.

Vittorio Oteri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.